Huldyrich F Günthard
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard H, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stoeckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso R, Andre P, Girardin F, Guidi M, Buclin T, Decosterd L, Swiss HIV Cohort Study S. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. Lancet Reg Health Eur 2023; 36:100793.
13.12.2023Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
13.12.2023Lancet Reg Health Eur 2023; 36:100793
Thoueille Paul, Alves Saldanha Susana, Schaller Fabian, Choong Eva, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldyrich F, Kusejko Katharina, Surial Bernard, Furrer Hansjakob, Rauch Andri, Rougemont Mathieu, Ustero Pilar, Calmy Alexandra, Stoeckle Marcel, Marzolini Catia, Di Benedetto Caroline, Bernasconi Enos, Schmid Patrick, Piso Rein Jan, Andre Pascal, Girardin François R, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Swiss HIV Cohort Study SHCS
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Begré L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, Béguelin C, Rockstroh J, Günthard H, Calmy A, Cavassini M, Stoeckle M, Schmid P, Bernasconi E, Levrero M, Zoulim F, Wandeler G, Rauch A, Swiss HIV Cohort Study (SHCS). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med 2023; 25:291-298.
10.10.2023Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
10.10.2023HIV Med 2023; 25:291-298
Begré Lorin, Boyd Anders, Salazar-Vizcaya Luisa, Suter-Riniker Franziska, Béguelin Charles, Rockstroh J K, Günthard Huldyrich F, Calmy Alexandra, Cavassini Matthias, Stoeckle Marcel, Schmid Patrick, Bernasconi Enos, Levrero Massimo, Zoulim Fabien, Wandeler Gilles, Rauch Andri, Swiss HIV Cohort Study (SHCS)
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
Schwenke J, Thorball C, Schoepf I, Ryom L, Hasse B, Lamy O, Calmy A, Wandeler G, Marzolini C, Kahlert C, Bernasconi E, Kouyos R, Günthard H, Ledergerber B, Fellay J, Burkhalter F, Tarr P, Swiss HIV Cohort Study S. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study. J Infect Dis 2023; 228:742-750.
15.09.2023Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
15.09.2023J Infect Dis 2023; 228:742-750
Schwenke Johannes M, Thorball Christian Wandell, Schoepf Isabella C, Ryom Lene, Hasse Barbara, Lamy Olivier, Calmy Alexandra, Wandeler Gilles, Marzolini Catia, Kahlert Christian, Bernasconi Enos, Kouyos Roger D, Günthard Huldyrich F, Ledergerber Bruno, Fellay Jacques, Burkhalter Felix, Tarr Philip X00a0 E, Swiss HIV Cohort Study SHCS
Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
Zeeb M, Tepekule B, Kusejko K, Reiber C, Kaelin M, Bartl L, Notter J, Furrer H, Hoffmann M, Hirsch H, Calmy A, Cavassini M, Labhardt N, Bernasconi E, Braun D, Günthard H, Kouyos R, Nemeth J, Swiss HIV Cohort Study S. Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland. Clin Infect Dis 2023
31.05.2023Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
31.05.2023Clin Infect Dis 2023
Zeeb Marius, Tepekule Burcu, Kusejko Katharina, Reiber Claudine, Kaelin Marisa B, Bartl Lena, Notter Julia, Furrer Hansjakob, Hoffmann Matthias, Hirsch Hans H., Calmy Alexandra, Cavassini Matthias, Labhardt Niklaus D, Bernasconi Enos, Braun Dominique Laurent, Günthard Huldyrich F, Kouyos Roger D, Nemeth Johannes, Swiss HIV Cohort Study SHCS
Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study.
Kusejko K, Smith D, Scherrer A, Paioni P, Kohns Vasconcelos M, Aebi-Popp K, Kouyos R, Günthard H, Kahlert C, Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study. JMIR Form Res 2023; 7:e44567.
31.05.2023Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study.
31.05.2023JMIR Form Res 2023; 7:e44567
Kusejko Katharina, Smith Daniel, Scherrer Alexandra U, Paioni Paolo, Kohns Vasconcelos Malte, Aebi-Popp Karoline, Kouyos Roger D, Günthard Huldyrich F, Kahlert Christian, Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S, Loosli T, Zaheri M, Frischknecht P, Huber M, Kusejko K, Yerly S, Leuzinger K, Perreau M, Ramette A, Wymant C, Fraser C, Kellam P, Gall A, Hirsch H, Stoeckle M, Rauch A, Cavassini M, Bernasconi E, Notter J, Calmy A, Günthard H, Metzner K, Kouyos R. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1. J Antimicrob Chemother 2023; 78:656-664.
02.03.2023Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
02.03.2023J Antimicrob Chemother 2023; 78:656-664
Balakrishna Suraj, Loosli Tom, Zaheri Maryam, Frischknecht Paul, Huber Michael, Kusejko Katharina, Yerly Sabine, Leuzinger Karoline, Perreau Matthieu, Ramette Alban Nicolas, Wymant Chris, Fraser Christophe, Kellam Paul, Gall Astrid, Hirsch Hans H., Stoeckle Marcel, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Notter Julia, Calmy Alexandra, Günthard Huldyrich F, Metzner Karin J, Kouyos Roger D
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
01.01.2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
01.01.2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study